(Q48308571)

10 February 2018

review article

1 reference

title

Alpha 2 adrenergic agonists. Neurochemistry, efficacy, and clinical guidelines for use in children. (English)

1 reference

10 February 2018

0 references

J H Newcorn

1

1 reference

10 February 2018

K Schulz

2

1 reference

10 February 2018

M Harrison

3

1 reference

10 February 2018

M D DeBellis

4

1 reference

10 February 2018

J K Udarbe

5

1 reference

10 February 2018

J M Halperin

6

1 reference

10 February 2018

publication date

1 October 1998

1 reference

10 February 2018

Pediatric Clinics of North America

published in

1 reference

10 February 2018

volume

45

1 reference

10 February 2018

issue

5

1 reference

10 February 2018

page(s)

1099-22, viii

1 reference

10 February 2018

Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. II. Adaptation to chronically presented stressful stimuli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Convergence of prefrontal and acoustic inputs upon neurons in the superior temporal gyrus of the awake squirrel monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

The effect of clonidine on the activity of neurons in the rat dorsal raphe nucleus in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Perikaryal and synaptic localization of alpha 2A-adrenergic receptor-like immunoreactivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Guanfacine as an alpha-2-agonist inducer of growth hormone secretion--a comparison with clonidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Noradrenergic mechanisms in stress and anxiety: II. Clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Case study: adverse response to clonidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Clonidine ameliorates Gilles de la Tourette syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Male testosterone linked to high social dominance but low physical aggression in early adolescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha 1- and alpha 2-adrenoceptors affect sleep and arousal mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Hypercapnia and hypoxia: chemoreceptor-mediated control of locus coeruleus neurons and splanchnic, sympathetic nerves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Guanfacine for Tourette's disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Bupropion hydrochloride in attention deficit disorder with hyperactivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Clonidine regularizes substantia nigra dopamine cell firing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Alpha 2A-adrenergic receptors are present in lower brainstem catecholaminergic and serotonergic neurons innervating spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Clonidine for posttraumatic stress disorder in preschool children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Mediation of separation distress by alpha 2-adrenergic mechanisms in a non-human primate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Noradrenergic suppression of synaptic transmission may influence cortical signal-to-noise ratio.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Clonidine in child and adolescent psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Clonidine treatment of hyperactive and impulsive children with autistic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Treatment of aggressive children with clonidine: results of an open pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Reduced turnover of dopamine and 5-hydroxytryptamine in discrete dopaminergic, noradrenergic and serotonergic rat brain areas after acutely administered medetomidine, a selective alpha 2-adrenoceptor agonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Clonidine treatment of Gilles de la Tourette's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Pathogenesis of Tourette's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Activity of cat locus coeruleus noradrenergic neurons during the defense reaction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Posttraumatic symptomatology in children and adolescents after an industrial fire.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

A neuroanatomical and biochemical basis for attention deficit disorder with hyperactivity in children: a defect in tonic adrenaline mediated inhibition of locus coeruleus stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Presynaptic alterations associated with enhancement of evoked release and synthesis of norepinephrine in hippocampus of chronically cold-stressed rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

A functional magnetic resonance imaging study of tic suppression in Tourette syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Catecholamines in attention-deficit hyperactivity disorder: current perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

The attention system of the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Locus coeruleus activity in monkey: phasic and tonic changes are associated with altered vigilance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Clonidine therapy for comorbid attention deficit hyperactivity disorder and conduct disorder: preliminary findings in a children's inpatient unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Alpha-2 receptor blockade increases responsiveness of locus coeruleus neurons to excitatory stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Abnormal noradrenergic function in posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Presynaptic alpha 2A-adrenoceptors inhibit the release of endogenous dopamine in rabbit caudate nucleus slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Comparison of the binding activities of some drugs on alpha 2A, alpha 2B and alpha 2C-adrenoceptors and non-adrenergic imidazoline sites in the guinea pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Modulation of rat brain α- and β-adrenergic receptor populations by lesions of the dorsal noradrenergic bundle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Distinct α-noradrenergic receptors differentiated by binding and physiological relationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Integration in the ventral medulla and coordination of sympathetic, pain and arousal functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Alpha-receptor-mediated facilitation of somatosensory cortical neuronal responses to excitatory synaptic inputs and iontophoretically applied acetylcholine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Membrane properties of rat locus coeruleus neurones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

Differential changes in noradrenaline turnover in specific regions of rat brain produced by controllable and uncontrollable shocks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970064-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(05)70064-X

1 reference

10 February 2018

PubMed ID

9884677

1 reference

10 February 2018